Healthcare

Biologic therapeutic market to hit $794.5b by 2029

Biologic therapeutic market to hit $794.5b by 2029

Thanks to the demand for monoclonal antibodies, gene and cell therapies, and vaccines.
1 day ago

What lies ahead for Taiwan’s neurosurgery robotic surgical systems market?

The sector is driven by the increasing demand for minimally invasive procedures.
2 days ago

China leads in clinical trials outside North America and Europe in Q2

Meanwhile, India overtook Iran to claim second place.
5 days ago

South Korea immunochemistry analyser market to grow 4% annually until 2036

One key driver is the shift toward high-precision diagnostic systems.
5 days ago

What’s driving the global influenza market?

One key growth factor is the rising prevalence of the disease.

Global pulse oximeters market to reach $7.03b by 2032

Emerging economies like India and China are becoming high-growth hotspots.

Respiratory care devices to be valued at $33.6b by 2030

A key growth factor is the growing elderly population.

Majority in India prefer diagnostic centres over hospitals: report

Individuals choose these facilities for preventive health checkups

Global hospital services to be valued at $24.17t by 2034

By hospital, the private hospital segment is anticipated to grow at the fastest rate.

Global venipuncture procedure market to hit $1.5b by 2030

Its growth is attributed to the increasing demand for diagnostic testing.

Remote surgery technology platforms market to hit $10.52b by 2034

Its growth is attributed to the rising demand for minimally invasive surgeries.

APAC eyes fastest growth in global cardiovascular information system market

Thanks to rapid urbanisation and increased healthcare spending.

Global cancer immunotherapy market to be valued at $247.2b by 2029

Developments in genomics, AI, and biotechnology are driving market growth.

APAC to see fastest growth in global care management solutions market

China, India, and Japan are investing heavily in healthcare IT infrastructure.

7MM sarcopenia market to see 8.1% CAGR growth until 2034

There are currently no approved drugs to treat the condition.